Articles

Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma

Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research
Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research
Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research
Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research
Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences
Department of Hematology, Imamura General Hospital
Department of Hematology, National Hospital Organization Kyushu Cancer Centre; Department of Cell Therapy National Hospital Organization Kyushu Cancer Centre
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences
Department of Hematology, National Hospital Organization Kyushu Cancer Centre
Department of Hematology, Oita Prefectural Hospital
Department of Hematology, National Hospital Organization Kumamoto Medical Center
Department of Hematology, Kumamoto University Hospital
Department of Hematology and Rheumatology, Kagoshima University Graduate School of Medical and Dental Sciences
Department of Hematology, Nagasaki University Hospital
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences
Department of Hematology, Imamura General Hospital
Cancer Institute, Japanese Foundation for Cancer Research
Department of Immunology, Nagoya University Graduate School of Medicine; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
Department of Immunology, Nagoya University Graduate School of Medicine; Department of Tumor Immunology, Aichi Medical University School of Medicine
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences; Department of Immunology, Nagoya University Graduate School of Medicine
Haematologica Early view Apr 14, 2022 https://doi.org/10.3324/haematol.2021.280352